Wechelderzande, Belgium

Mirielle Braeken

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 7.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Peer, BE (2002)
  • Vlimmeren, BE (2013)
  • Wechelderzande, BE (2015 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mirielle Braeken: Innovator in Pharmaceutical Chemistry

Introduction

Mirielle Braeken is a prominent inventor based in Wechelderzande, Belgium. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of six patents to her name, her work focuses on creating effective inhibitors for various medical applications.

Latest Patents

Among her latest patents, Mirielle has developed piperidine and piperazine derivatives that serve as DGAT inhibitors. These inventions include complex chemical formulas that detail the structural components and potential applications of these compounds. The patents outline methods for preparing these compounds, their pharmaceutical compositions, and their use as medicines, showcasing her expertise in medicinal chemistry.

Career Highlights

Mirielle Braeken has built a successful career at Janssen Pharmaceutica NV, where she has been instrumental in advancing research and development in the pharmaceutical sector. Her innovative approach and dedication to her work have positioned her as a key figure in her field.

Collaborations

Throughout her career, Mirielle has collaborated with notable colleagues, including Joannes Theodorus Maria Linders and Lieven Meerpoel. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Mirielle Braeken's contributions to pharmaceutical chemistry through her innovative patents and collaborative efforts highlight her as a leading inventor in her field. Her work continues to impact the development of new medical treatments and compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…